FDA approves Roche’s Actemra/RoActemra treatment for rare lung disease
March 5, 2021Medical Communications Actemra, RoActemra, Roche, SEC, systemic sclerosis
Roche’s Actemra/RoActemra therapy, intended for slowing the rate of decline in pulmonary function for adults with systemic sclerosis-associated interstitial lung …
Amgen to acquire Five Prime Therapeutics for approximately $1.9bn
March 5, 2021Medical Communications Amgen, Cancer, five prime
Amgen has announced it will acquire Five Prime Therapeutics for $38.00 per share in cash, representing an equity value of …
Novartis signs agreement to manufacture CureVac’s COVID-19 vaccine
March 5, 2021Medical Communications COVID-19, CureVac, Novartis, vaccines
CureVac and Novartis have signed an initial agreement for the manufacturing of CureVac’s COVID-19 vaccine candidate, CVnCoV. Preparations for the …
UK government invests £5m in COVID-19 mRNA vaccine library
March 5, 2021Medical Communications COVID-19, CPI, government, vaccines
The Centre for Process Innovation (CPI) has received a £5 million investment from the UK government, to support the development …
Takeda agree $856m deal with Ovid to take over soticlestat development
March 4, 2021Ovid, Takeda, epilepsy treatment, epiplepsy, soticlestat
Ovid Therapeutics and Takeda have agreed a deal worth up to $856 million, allowing the latter to take over development …
Beyond Batten Disease Foundation partners with Actelion on development of combination treatment
March 4, 2021Actelion, Batten disease, Janssen
Beyond Batten Disease Foundation (BBDF) has partnered with Actelion Pharmaceuticals, a Janssen company, to provide Zavesca (miglustat) for the development of …
Bharat Biotech’s COVAXIN jab 81% effective in Phase III trial
March 4, 2021Bharat Biotech, COVID-19, COVID-19 vaccine, Vaccine, bharat
Bharat Biotech’s COVID-19 vaccine candidate has shown an interim efficacy of 81% in a Phase III trial, the company announced …
Hong Kong Baptist University researchers develop drug for EBV-associated cancers
March 4, 2021Cancer, Epstein-barr virus, Hong Kong
Researchers at Hong Kong Baptist University have developed a novel drug with the potential to become a next-generation treatment for …
ConserV and eTheRNA partner on infectious disease vaccines
March 4, 2021ConserV, eTheRNA, vaccines
ConserV Bioscience and eTheRNA immunotherapies have agreed to collaborate on the development of vaccine candidates for infectious diseases. ConserV is …
Pharmafile.com’s weekly COVID-19 news round-up
March 3, 2021Research and Development
The past week has continued to see positive COVID-19 news; COVAX has delivered their first batch of vaccines to Africa, …
ViaCyte and Gore collaborate on new diabetes treatments
March 3, 2021Research and Development Type 1 diabetes, diabetes, diabetes treatment, gore, viacyte
Clinical stage medicine company ViaCyte have extended their collaboration with materials science organisation Gore to develop new candidates for the …
AbbVie funds Mitokinin’s Parkinson’s research with option to buy
March 3, 2021Research and Development AbbVie, Mitokinin, Parkinson's
AbbVie has landed an option to buy neurodegenerative disease-focused biotech Mitokinin following completion of investigational new drug (IND)-enabling studies on …
NHS England increases access to cladribine tablets for multiple sclerosis patients during pandemic
March 3, 2021Research and Development Cladribine, Mavenclad, Merck, multiple sclerosis
NHS England has updated the Blueteq requirements for patients with highly active relapsing MS starting Merck’s cladribine (Mavenclad) tablets during …
AstraZeneca wins US court ruling on Symbicort patent claims
March 3, 2021Research and Development AstraZeneca, Symbicort, law
A US district court has ruled in favour of AstraZeneca in litigation against Mylan Pharmaceuticals and Kindeva Drug Delivery, AstraZeneca …
Verona Pharma appoints Novartis Gene Therapies VP Lisa Deschamps to its board
March 2, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, verona, verona pharma
Verona Pharma has appointed Lisa Deschamps, Senior Vice President and Chief Business Officer of Novartis Gene Therapies, as Non-Executive Director …
SERB acquires BTG to expand its treatment portfolio for unmet medical needs
March 2, 2021Manufacturing and Production BTG, SERB, specialty pharmaceuticals
SERB Specialty Pharmaceuticals has purchased BTG Specialty Pharmaceuticals, a division of Boston Scientific that develops treatments with critical conditions, for …
Single Pfizer or AstraZeneca vaccine dose drastically reduces COVID-19 hospitalisations in over-80s
March 2, 2021Manufacturing and Production AstraZeneca, COVID-19, COVID-19 vaccine, Pfizer, Vaccine
A single dose of the Oxford-AstraZeneca or the Pfizer-BioNTech vaccine reduces UK hospitalisations in over-80s by 80%, a Public Health …
Abivax appoints Dr Sophie Biguenet as Chief Medical Officer
March 2, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Clinical-stage biotechnology company Abivax has appointed Dr Sophie Biguenet as Chief Medical Officer. Dr Biguenet brings 25 years of experience …
Cancer Research UK joins forces with Teon to develop new cancer drug
March 2, 2021Manufacturing and Production Cancer, Cancer Research UK, Teon
Cancer Research UK and Teon Therapeutics have entered a collaboration agreement to progress the early phase clinical development of Teon’s new cancer drug. The partnership …
CN Bio receives UK government grant to develop single and multi-organ models for COVID-19 research
March 2, 2021Manufacturing and Production CN Bio, COVID-19
CN Bio, a leading developer of single and multi-organ microphysiological systems (MPS), has received a grant from innovation agency Innovate …
Latest content
